Crossmark

Targeted 1H NMR metabolomics and immunological phenotyping of human fresh blood and serum samples discriminate between healthy individuals and inflammatory bowel disease patients treated with anti-TNF

Crossref DOI link: https://doi.org/10.1007/s00109-021-02094-y

Published Online: 2021-05-21

Published Print: 2021-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Notararigo, Sara https://orcid.org/0000-0001-9841-5500
Martín-Pastor, Manuel

Viñuela-Roldán, Juan E.

Quiroga, Adriano

Dominguez-Munoz, J. Enrique

Barreiro-de Acosta, Manuel
License Information

Text and Data Mining valid from 2021-05-21

Version of Record valid from 2021-05-21
More Information

Article History

Received: 30 October 2020

Revised: 19 April 2021

Accepted: 13 May 2021

First Online: 21 May 2021

Change Date: 4 June 2021

Change Type: Update

Change Details: Author name tagging correction.

Declarations

:

: This study passed the ethical approval of Comité de Etica de la Investigación de Santiago-Lugo CEIC 2018/410, on the 20/09/2018.

: Informed consent was obtained from all participants.

: Consent for publication was obtained with the ethical approvals.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below